Biswas, S., Srivastava, Y., Hamadttu, A. (2026). Comparative effectiveness of first-line ribociclib plus aromatase inhibitor versus palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer: A global real-world evidence study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.45